Bladder Cancer Executive Market Summary

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Buck Institute for Age Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Buck Institute for Age Research - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • April 2014
  • 18 pages

Summary Buck Institute for Research on Aging (Buck Institute) is a research and education center. The organization concentrates on extending the health-span, the healthy years of each individual's life. Buck Institute provides research to understanding the connection between aging and chronic disease. ...

Industries: Pathology | Countries: United States, North America

Dana-Farber Cancer Institute, Inc. - Medical Equipment - Deals and Alliances Profile

Dana-Farber Cancer Institute, Inc. - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • by Global Data
  • April 2014
  • 26 pages

Summary Dana-Farber Cancer Institute, Inc. (Dana-Farber) is a cancer research center. The center offers treatment for different types of cancers. It provides adults and children with various treatment options. The center offers ongoing clinical trials for cancer at Dana-Farber and affiliated institutions. ...

Industries: Pathology | Countries: United States, North America

Lialda (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Lialda (Ulcerative Colitis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 47 pages

Lialda (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson's (J&J's) Simponi and Takeda's Entyvio, which will lead to an increase in the overall number of patients ...

Industries: Pathology | Countries: Canada, Japan, United States, Spain, Italy, Germany, World, United Kingdom, North America, Europe

Uceris (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Uceris (Ulcerative Colitis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 46 pages

Uceris (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson's (J&J's) Simponi and Takeda's Entyvio, which will lead to an increase in the overall number of patients ...

Industries: Pathology | Countries: Canada, United States, Spain, Italy, France, Germany, World, United Kingdom, Japan, Europe, North America

Humira (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Humira (Ulcerative Colitis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 48 pages

Humira (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson's (J&J's) Simponi and Takeda's Entyvio, which will lead to an increase in the overall number of patients ...

Industries: Pathology | Countries: Japan, Canada, United States, Spain, Italy, France, Germany, World, Europe, United Kingdom, North America

Simponi (Ulcerative Colitis) - Forecast and Market Analysis to 2022

Simponi (Ulcerative Colitis) - Forecast and Market Analysis to 2022

  • $ 3 495
  • Industry report
  • by Global Data
  • February 2014
  • 46 pages

Simponi (Ulcerative Colitis) - Forecast and Market Analysis to 2022 Summary During the forecast period from 2012-2022, the growth of the UC market will be driven largely by the entry of Johnson & Johnson's (J&J's) Simponi and Takeda's Entyvio, which will lead to an increase in the overall number of patients ...

Industries: Pathology | Countries: Canada, Japan, United States, Spain, Italy, France, Germany, World, United Kingdom, Europe, North America

Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including G

Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including G

  • $ 10 995
  • Industry report
  • by iData Research, Inc.
  • October 2013
  • 180 pages

Global Procedures for Fractures and Degenerative Disc Disease (North America, including Canada and the United States; Oceania, including Australia and New Zealand; Latin America, including Argentina, Mexico, Brazil and Other Countries; Europe, including Germany, Frange, the U.K., Italy, Spain, Belgium, ...

Industries: Pathology | Countries: World, Europe, South America, Australia, Argentina, North America, Brazil, Mexico, Oceania, Canada, Switzerland, Netherlands, Sweden, Spain, Portugal, Italy, Germany, Finland, Denmark, Belgium, Austria

EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022

EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022

  • $ 3 995
  • Industry report
  • by Global Data
  • January 2013
  • 56 pages

EpiCast Report: Crohn's Disease Epidemiology Forecast to 2022 Summary Crohn's disease is a form of inflammatory bowel disease (IBD) characterized by recurrent inflammation of all or part of the gastrointestinal tract (CDC, 2011). Globally, the incidence rates for Crohn's disease vary between 0.3 cases ...

Industries: Pathology | Countries: United States, Canada, Japan, India, China, Spain, Italy, France, Germany, World, United Kingdom, Europe, Asia, North America

Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017

Neuromodulation Market - [Spinal Cord Stimulation (SCS), Vagus Nerve Stimulation (VNS), Gastric Electrical Stimulation (GES), Deep Brain Stimulation (DBS), Sacral Nerve Stimulation (SNS) & Transcranial Magnetic Stimulation (TMS)] - Forecasts to 2017

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • January 2013
  • 193 pages

Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market due to high demand for minimally invasive and non-invasive treatment. With advancements in technology, neuromodulation is expected to become a promising therapeutic area and high growth industry in ...

Industries: Pathology | Countries: World, North America, United States, Europe

Global Hearing Instruments Market Report: 2012 Edition

Global Hearing Instruments Market Report: 2012 Edition

  • $ 800
  • Industry report
  • by Koncept Analytics
  • December 2012
  • 53 pages

In the last few years there has been a significant increase in the population suffering from hearing problems. On account of the evolving technological environment, companies operating in the healthcare and medical technology industry are now scaling new peaks. Also, the respective sector's growth is ...

Industries: Pathology | Countries: World, United States, South Korea, North America, United Kingdom

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.